Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

All is not lost: learning from 9p21 loss in cancer

1 Apr 2022

Abstract excerpt

The cancer research community continues to search for additional biomarkers of response and resistance to immune checkpoint treatment (ICT). The ultimate goal is to direct the use of ICT in patients whose tumors are most likely to benefit to achieve a refinement that is equivalent to that of a genotype-matched targeted treatment. Dissecting the mechanisms of ICT resistance can help us characterize ICT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35379580
DOI: 10.1016/j.it.2022.03.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

All is not lost: learning from 9p21 loss in cancerPMID 35379580Read ↗

9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapySemantic proximity Read ↗

Somatic 9p24.1 alterations in HPV – head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activitySemantic proximity Read ↗

Chromosome 9p21.3 Coordinates Cell Intrinsic and Extrinsic Tumor SuppressionSemantic proximity Read ↗

MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasisSemantic proximity Read ↗

Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer typesSemantic proximity Read ↗

Immune evasion in HPV − head and neck precancer–cancer transition is driven by an aneuploid switch involving chromosome 9p lossSemantic proximity Read ↗

Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasionSemantic proximity Read ↗

3p21.3 tumor suppressor cluster: prospects for translational applicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.